Risk | Very High | Very High |
Rating | 5.0 | 3.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.93 | 1.92 |
NAV | ₹37.55 | ₹40.36 |
Fund Started | 25 Jun 2018 | 12 Nov 2018 |
Fund Size | ₹5024.00 Cr | ₹3138.46 Cr |
Exit Load | Exit load of 1% if redeemed within 15 days. | Exit load of 0.50% if redeemed within 1 month. |
1 Year | 50.65% | 49.05% |
3 Year | 22.29% | 21.11% |
5 Year | 30.36% | 30.89% |
Equity | 97.87% | 96.59% |
Cash | 2.13% | 3.41% |
Top 10 Holdings |
|
|
Name | Dharmesh Kakkad | Jay Kothari |
Start Date | 23 Feb 2021 | 16 Mar 2018 |
Description | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. |
Launch Date | 25 Jun 2018 | 12 Nov 2018 |